 medulloblastoma freedom relaps year therapeut cure seventy-seven patient medulloblastoma stanford univers medic center multimod therapi util surgic extirp megavoltag irradi case chemotherapi adjunct treatment actuari surviv rate maximum follow-up period median year treatment failur year tumor-fre surviv gross total remov tumor patient surgic mortal rate signific differ incid metastat diseas patient classic form medulloblastoma present case desmoplast subtyp surviv rate patient desmoplast tumor patient high-dos irradi equal cgi posterior fossa earli data freedom relaps possibl benefici effect chemotherapi long-term follow-up result advantag modal treatment pattern relaps surviv relaps central nervou system collin rule applic case period risk patient recurr diseas none long-term survivor studi data freedom relaps year diagnosi cure diseas long-term follow-up monitor essenti efficaci treatment surviv pattern